Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 7 (2007), Pages 231-238
http://dx.doi.org/10.1100/tsw.2007.214
Mini-Review Article

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms

Departments of Psychiatry and Behavioral Sciences and Neurology, The Johns Hopkins School of Medicine, Johns Hopkins Bayview Medical Center, 5501 Hopkins Bayview Drive, Baltimore, MD 21224, USA

Received 22 June 2007; Revised 13 July 2007; Accepted 25 July 2007

Academic Editors: D. Shurtleff and S. Ferre

Copyright © 2007 Una McCann and George A. Ricaurte.

Citations to this Article [32 citations]

The following is the list of published articles that have cited the current article.

  • Una D. McCann, Francis P. Sgambati, Alan R. Schwartz, and George A. Ricaurte, “Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers,” Neurology, vol. 73, no. 23, pp. 2011–2017, 2009. View at Publisher · View at Google Scholar
  • Una D. McCann, Michael J. Wilson, Francis P. Sgambati, and George A. Ricaurte, “Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("ecstasy") users,” Journal of Neuroscience, vol. 29, no. 44, pp. 14050–14056, 2009. View at Publisher · View at Google Scholar
  • Surilla Randall, Chris-Ellyn Johanson, Manuel Tancer, and Timothy Roehrs, “Effects of Acute 3, 4-Methylenedioxymethamphetamine on Sleep and Daytime Sleepiness in MDMA Users: A Preliminary Study,” Sleep, vol. 32, no. 11, pp. 1513–1519, 2009. View at Publisher · View at Google Scholar
  • Parrott, “Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users,” Neuropsychobiology, vol. 60, no. 3-4, pp. 148–158, 2009. View at Publisher · View at Google Scholar
  • Robin L. Carhart-Harris, David J. Nutt, Marcus R. Munafo, David M. Christmas, and Sue J. Wilson, “Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls,” Psychopharmacology, vol. 206, no. 2, pp. 187–196, 2009. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, “Psychobiology of MDMA Preface,” Neuropsychobiology, vol. 60, no. 3-4, pp. 117–118, 2009. View at Publisher · View at Google Scholar
  • Kirk J. Brower, and Brian E. Perron, “Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances,” Medical Hypotheses, vol. 74, no. 5, pp. 928–933, 2010. View at Publisher · View at Google Scholar
  • Rowan P. Ogeil, Shantha M.W. Rajaratnam, Jennifer R. Redman, and Jillian H. Broadbear, “Acute MDMA administration alters the distribution and circadian rhythm of wheel running activity in the rat,” Brain Research, vol. 1359, pp. 128–136, 2010. View at Publisher · View at Google Scholar
  • Norbert Gyongyosi, Brigitta Balogh, Zita Katai, Eszter Molnar, Rudolf Laufer, Kornelia Tekes, and Gyorgy Bagdy, “Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment,” Journal of Neural Transmission, vol. 117, no. 3, pp. 285–292, 2010. View at Publisher · View at Google Scholar
  • Alvarenga, Ribeiro, Araujo, Hirotsu, Mazaro-Costa, Costa, Battisti, Tufik, and Andersen, “Sleep loss and acute drug abuse can induce DNA damage in multiple organs of mice,” Human and Experimental Toxicology, vol. 30, no. 9, pp. 1275–1281, 2011. View at Publisher · View at Google Scholar
  • Alinde E. Wallinga, Carolin Grahlmann, Ramon A. Granneman, Jaap M. Koolhaas, and Bauke Buwalda, “Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats,” Brain Research, vol. 1398, pp. 13–20, 2011. View at Publisher · View at Google Scholar
  • Amy L. Bauernfeind, Mary S. Dietrich, Jennifer U. Blackford, Evonne J. Charboneau, James G. Lillevig, Christopher J. Cannistraci, Neil D. Woodward, Aize Cao, Tristan Watkins, Christina R. Di Iorio, Carissa Cascio, Ronald M. Salomon, and Ronald L. Cowan, “Human ecstasy use is associated with increased cortical excitability: An fMRI study,” Neuropsychopharmacology, vol. 36, no. 6, pp. 1127–1141, 2011. View at Publisher · View at Google Scholar
  • Una D. Mccann, Robert R. Edwards, Michael T. Smith, Kristen Kelley, Michael Wilson, Francis Sgambati, and George Ricaurte, “Altered pain responses in abstinent (±)3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") users,” Psychopharmacology, vol. 217, no. 4, pp. 475–484, 2011. View at Publisher · View at Google Scholar
  • Rowan P. Ogeil, David J. Kennaway, Mark D. Salkeld, Shantha M. W. Rajaratnam, and Jillian H. Broadbear, “MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei,” Psychopharmacology, vol. 220, no. 4, pp. 835–843, 2011. View at Publisher · View at Google Scholar
  • Lynn T. Singer, Derek G. Moore, Sarah Fulton, Julia Goodwin, John J.D. Turner, Meeyoung O. Min, and Andrew C. Parrott, “Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy,” Neurotoxicology and Teratology, vol. 34, no. 3, pp. 303–310, 2012. View at Publisher · View at Google Scholar
  • Christina R. Di Iorio, Tristan J. Watkins, Mary S. Dietrich, Aize Cao, Jennifer U. Blackford, Baxter Rogers, Mohammed S. Ansari, Ronald M. Baldwin, Rui Li, Robert M. Kessler, Ronald M. Salomon, Margaret Benningfield, and Ronald L. Cowan, “Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users,” Archives of General Psychiatry, vol. 69, no. 4, pp. 399–409, 2012. View at Publisher · View at Google Scholar
  • Iman Parhami, Aaron Siani, Richard J. Rosenthal, and Timothy W. Fong, “Pathological Gambling, Problem Gambling and Sleep Complaints: An Analysis of the National Comorbidity Survey: Replication (NCS-R),” Journal of Gambling Studies, vol. 29, no. 2, pp. 241–253, 2012. View at Publisher · View at Google Scholar
  • Iman Parhami, Aaron Siani, Richard J. Rosenthal, Stephanie Lin, Michael Collard, and Timothy W. Fong, “Sleep and Gambling Severity in a Community Sample of Gamblers,” Journal of Addictive Diseases, vol. 31, no. 1, pp. 67–79, 2012. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research,” Human Psychopharmacology: Clinical and Experimental, vol. 28, no. 4, pp. 289–307, 2013. View at Publisher · View at Google Scholar
  • Ana Adan, “A chronobiological approach to addiction,” Journal of Substance Use, vol. 18, no. 3, pp. 171–183, 2013. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, “MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users,” Neuroscience & Biobehavioral Reviews, 2013. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, Cathy Montgomery, Mark A. Wetherell, Luke A. Downey, Con Stough, and Andrew B. Scholey, “MDMA, cortisol, and heightened stress in recreational ecstasy users,” Behavioural Pharmacology, vol. 25, no. 5-6, pp. 458–472, 2014. View at Publisher · View at Google Scholar
  • Ryan Vandrey, Kimberly A. Babson, Evan S. Herrmann, and Marcel O. Bonn-Miller, “Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders,” International Review of Psychiatry, vol. 26, no. 2, pp. 237–247, 2014. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, “The Potential Dangers of Using MDMA for Psychotherapy,” Journal of Psychoactive Drugs, vol. 46, no. 1, pp. 37–43, 2014. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, Derek G. Moore, John J.D. Turner, Julia Goodwin, Meeyoung O. Min, and Lynn T. Singer, “MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy,” Human Psychopharmacology: Clinical and Experimental, vol. 29, no. 1, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, “Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation,” Human Psychopharmacology: Clinical and Experimental, vol. 30, no. 4, pp. 213–224, 2015. View at Publisher · View at Google Scholar
  • Phil Evans, Tobias Stalder, Andrew C. Parrott, Luke A. Downey, Helen Sands, Lewis Jones, and Angela Clow, “Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits,” Human Psychopharmacology: Clinical and Experimental, vol. 30, no. 3, pp. 199–207, 2015. View at Publisher · View at Google Scholar
  • Andrew C. Parrott, “Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: Neurohormonal aspects of recreational 'ecstasy',” Behavioural Pharmacology, vol. 27, no. 8, pp. 649–658, 2016. View at Publisher · View at Google Scholar
  • Phil Reed, Lewis Jones, and Andrew Parrott, “Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users,” Journal of Psychopharmacology, vol. 30, no. 12, pp. 1313–1320, 2016. View at Publisher · View at Google Scholar
  • C.A. Roberts, B.B. Quednow, C. Montgomery, and A.C. Parrott, “MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users,” Neuroscience & Biobehavioral Reviews, 2017. View at Publisher · View at Google Scholar
  • Andrew C Parrott, Luke A Downey, Carl A Roberts, Cathy Montgomery, Raimondo Bruno, and Helen C Fox, “Recreational 3,4-methylenedioxymethamphetamine or ?ecstasy?: Current perspective and future research prospects,” Journal of Psychopharmacology, pp. 026988111771192, 2017. View at Publisher · View at Google Scholar
  • Joseph J. Palamar, Pia M. Mauro, Benjamin H. Han, and Silvia S. Martins, “Shifting characteristics of ecstasy users ages 12–34 in the United States, 2007–2014,” Drug and Alcohol Dependence, vol. 181, pp. 20–24, 2017. View at Publisher · View at Google Scholar